JP4782671B2 - 低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体 - Google Patents

低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体 Download PDF

Info

Publication number
JP4782671B2
JP4782671B2 JP2006508164A JP2006508164A JP4782671B2 JP 4782671 B2 JP4782671 B2 JP 4782671B2 JP 2006508164 A JP2006508164 A JP 2006508164A JP 2006508164 A JP2006508164 A JP 2006508164A JP 4782671 B2 JP4782671 B2 JP 4782671B2
Authority
JP
Japan
Prior art keywords
phl
allergen
variant
seq
allergies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006508164A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007536893A (ja
JP2007536893A5 (enExample
Inventor
ヴァルト,マルティン
クロムウェル,オリヴァー
ナンディー,アンドレーアス
カーレルト,ヘルガ
ヴェーバー,ベルンハルト
フィービク,ヘルムート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of JP2007536893A publication Critical patent/JP2007536893A/ja
Publication of JP2007536893A5 publication Critical patent/JP2007536893A5/ja
Application granted granted Critical
Publication of JP4782671B2 publication Critical patent/JP4782671B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55561CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2006508164A 2003-06-04 2004-05-06 低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体 Expired - Fee Related JP4782671B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10325508 2003-06-04
DE10325508.7 2003-06-04
PCT/EP2004/004848 WO2004108758A1 (de) 2003-06-04 2004-05-06 Phl p 5a-derivate mit reduzierter allergenität und erhaltener t-zellreaktivität

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010207438A Division JP5363441B2 (ja) 2003-06-04 2010-09-16 低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体

Publications (3)

Publication Number Publication Date
JP2007536893A JP2007536893A (ja) 2007-12-20
JP2007536893A5 JP2007536893A5 (enExample) 2010-11-11
JP4782671B2 true JP4782671B2 (ja) 2011-09-28

Family

ID=33494849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006508164A Expired - Fee Related JP4782671B2 (ja) 2003-06-04 2004-05-06 低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体
JP2010207438A Expired - Fee Related JP5363441B2 (ja) 2003-06-04 2010-09-16 低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010207438A Expired - Fee Related JP5363441B2 (ja) 2003-06-04 2010-09-16 低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体

Country Status (13)

Country Link
US (3) US8628946B2 (enExample)
EP (3) EP2272863B1 (enExample)
JP (2) JP4782671B2 (enExample)
CN (1) CN1798763B (enExample)
AT (1) ATE513848T1 (enExample)
AU (1) AU2004245184B2 (enExample)
BR (1) BRPI0410908A (enExample)
CA (1) CA2528053C (enExample)
ES (3) ES2397778T3 (enExample)
PL (2) PL2287180T3 (enExample)
PT (3) PT2272863E (enExample)
RU (1) RU2368620C2 (enExample)
WO (1) WO2004108758A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR779201A0 (en) 2001-09-20 2001-10-11 University Of Melbourne, The Immunotherapeutic and immunoprophylactic reagents
US8628946B2 (en) * 2003-06-04 2014-01-14 Merck Patent Gmbh Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
EP3170510A1 (de) * 2010-01-14 2017-05-24 Merck Patent GmbH Varianten der gruppe 5-allergene der süssgräser mit reduzierter allergenität durch mutagenese von prolinresten
US20230242922A1 (en) 2021-09-13 2023-08-03 Life Technologies Corporation Gene editing tools

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511842A (ja) * 1997-03-27 2002-04-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 特異的免疫療法のためのイネ科花粉アレルゲン変異体及びそれらの製造及び使用
WO2002040676A2 (en) * 2000-11-16 2002-05-23 Alk-Abelló A/S Mutant allergens
WO2003025009A1 (en) * 2001-09-20 2003-03-27 The University Of Melbourne RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
DE19918682A1 (de) 1999-04-23 2000-10-26 Merck Patent Gmbh DNA-Sequenz und rekombinante Herstellung eines Graminaen-Allergens
IT1318692B1 (it) 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
US8628946B2 (en) * 2003-06-04 2014-01-14 Merck Patent Gmbh Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511842A (ja) * 1997-03-27 2002-04-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 特異的免疫療法のためのイネ科花粉アレルゲン変異体及びそれらの製造及び使用
WO2002040676A2 (en) * 2000-11-16 2002-05-23 Alk-Abelló A/S Mutant allergens
WO2003025009A1 (en) * 2001-09-20 2003-03-27 The University Of Melbourne RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY

Also Published As

Publication number Publication date
PT2287180E (pt) 2013-10-31
PT1629006E (pt) 2011-09-28
US20160207967A1 (en) 2016-07-21
AU2004245184A1 (en) 2004-12-16
EP1629006A1 (de) 2006-03-01
PL2287180T3 (pl) 2013-12-31
US9522938B2 (en) 2016-12-20
ES2397778T3 (es) 2013-03-11
EP2287180B9 (de) 2013-11-06
JP2007536893A (ja) 2007-12-20
JP2011041566A (ja) 2011-03-03
CN1798763A (zh) 2006-07-05
CA2528053C (en) 2014-08-12
PT2272863E (pt) 2013-01-30
BRPI0410908A (pt) 2006-06-27
ES2367633T3 (es) 2011-11-07
ATE513848T1 (de) 2011-07-15
JP5363441B2 (ja) 2013-12-11
PL2272863T3 (pl) 2013-03-29
EP2272863A1 (de) 2011-01-12
US20100158955A1 (en) 2010-06-24
US20140255434A1 (en) 2014-09-11
CA2528053A1 (en) 2004-12-16
US8628946B2 (en) 2014-01-14
AU2004245184B2 (en) 2011-03-24
WO2004108758A1 (de) 2004-12-16
RU2368620C2 (ru) 2009-09-27
ES2434720T3 (es) 2013-12-17
EP2287180B1 (de) 2013-08-07
RU2005141524A (ru) 2006-09-10
EP2287180A1 (de) 2011-02-23
CN1798763B (zh) 2010-05-26
EP2272863B1 (de) 2012-10-31
EP1629006B1 (de) 2011-06-22

Similar Documents

Publication Publication Date Title
JP5363441B2 (ja) 低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体
JP4588888B2 (ja) イネ科アレルゲンのdna配列および組換え体産生
RU2409589C2 (ru) ВАРИАНТ АЛЛЕРГЕНА ГРУППЫ I ИЗ Роасеае, ХАРАКТЕРИЗУЮЩИЙСЯ СНИЖЕННОЙ АЛЛЕРГЕННОСТЬЮ И СОХРАНЕННОЙ Т-КЛЕТОЧНОЙ РЕАКТИВНОСТЬЮ (ВАРИАНТЫ), КОДИРУЮЩАЯ ЕГО МОЛЕКУЛА ДНК И ЕГО ПРИМЕНЕНИЕ
US7485305B2 (en) Allergen from house-dust mites
CN100391970C (zh) 草花粉过敏原Phl p4 的 DNA 序列和用重组方法进行的制备
JP4745237B2 (ja) パリエタリアジュダイカの主要アレルゲンの低アレルギー性変異体、その使用およびそれらを含む組成物
JP2007536893A5 (enExample)
JP4960102B2 (ja) 穀物からの4群主要アレルゲンのdna配列および組換え製剤
CN102791289B (zh) 因脯氨酸残基突变而具有降低变应原性的真禾本科第5组变应原的变体
US8999348B2 (en) Variants of group 6 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues
AU2012205288A1 (en) DNA-sequence and recombinant production of group 4 major allergens from cereals

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100316

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100616

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100623

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100716

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100726

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100816

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100916

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20100916

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110509

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110607

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110707

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140715

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees